Scientech Research LLC’s Colgate-Palmolive CL Stock Holding History

Scientech Research LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,528	Closed	-$230K	–	601
2024 Q4	$230K	Buy	+2,528	New	+$241K	0.07%	476

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Scientech Research LLC's CL Position: Q1 2025 in Review

Scientech Research LLC sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 2,528 shares — an estimated $230K sold.

Scientech Research LLC first reported a position in CL in Q4 2024 and held it in 1 quarter. The position peaked at $230K in Q4 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Scientech Research LLC reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
Scientech Research LLC sold 2,528 Colgate-Palmolive shares in Q1 2025, an estimated $230K.
Scientech Research LLC first reported a position in Colgate-Palmolive in Q4 2024 and held it in 1 quarter.
Scientech Research LLC's Colgate-Palmolive position peaked at $230K in Q4 2024.
1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Scientech Research LLC's 13F filing for Q1 2025, filed 15 May 2025.